RT @doctorRBC: Methotrexate plus leflunomide combination therapy for PsA treatment resulted in greater improvement in di
Tweet Content
Methotrexate plus leflunomide combination therapy for PsA treatment resulted in greater improvement in disease activity when compared to MTX monotherapy. As expected, MTX+LEF less well tolerated.
@RheumNow #EULAR2022 ABST#0078 https://t.co/Bo64QX3Bf9
Show on Archive Page
On
Display in Search Results
On
PDQ
Off